NCT02445807View on ClinicalTrials.gov

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Chronic Stable Plaque Psoriasis
Interventions
DRUG

DFD06-Cream

Twice daily topical application for 14 days.

DRUG

Vehicle Cream

Twice daily topical application for 14 days.

Trial Locations (30)

11790

Site 117, Stony Brook

20769

Site 105, Glenn Dale

27157

Site 109, Winston-Salem

27262

Site 124, High Point

29607

Site 102, Greenville

29621

Site 119, Anderson

33144

Site 115, Miami

33756

Site 128, Clearwater

35205

Site 101, Birmingham

36608

Site 103, Mobile

40202

Site 110, Louisville

46256

Site 118, Indianapolis

48088

Site 111, Warren

55432

Site 113, Fridley

64506

Site 123, Saint Joseph

75024

Site 107, Plano

77030

Site 122, Houston

78759

Site 108, Austin

84020

Site 112, Draper

85202

Site 130, Mesa

85251

Site 116, Phoenix

85712

Site 125, Tucson

87106

Site 104, Albuquerque

90404

Site 127, Santa Monica

91606

Site 120, North Hollywood

92117

Site 114, San Diego

99202

Site 126, Spokane

99362

Site 121, Walla Walla

03801

Site 106, Newington

02919

Site 129, Johnston

All Listed Sponsors
lead

Promius Pharma, LLC

INDUSTRY

NCT02445807 - A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter